Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts

The utility of plasma amyloid beta (Aβ) and tau levels for the clinical diagnosis of Alzheimer’s disease (AD) dementia has been controversial. The main objective of this study was to compare Aβ42 and tau levels measured by the ultra-sensitive immunomagnetic reduction (IMR) assays in plasma samples c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lue, Lih-Fen, Sabbagh, Marwan N., Chiu, Ming-Jang, Jing, Naomi, Snyder, Noelle L., Schmitz, Christopher, Guerra, Andre, Belden, Christine M., Chen, Ta-Fu, Yang, Che-Chuan, Yang, Shieh-Yueh, Walker, Douglas G., Chen, Kewei, Reiman, Eric M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522888/
https://www.ncbi.nlm.nih.gov/pubmed/28790911
http://dx.doi.org/10.3389/fnagi.2017.00226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522888/
https://www.ncbi.nlm.nih.gov/pubmed/28790911
http://dx.doi.org/10.3389/fnagi.2017.00226

Ejemplares similares